Focalin Sales May Be Weak...But It Won't Hurt This Stock

By: via Benzinga
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ: IPCI) shares are down 48 percent year-to-date, plunging in August, and continuing a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.